Several studies have shown that fusion cells have the potential to induce CD4+ as well as CD8+ T-cell mediated antitumor immunity, protection from an otherwise lethal challenge of tumor, and even regression of established metastatic disease [15,26-28]. Here, CD8A is linked to metastatic neoplasm.